First Trust Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.56M | Buy |
302,280
+60,114
| +25% | +$1.3M | 0.01% | 1235 |
|
|
2025
Q1 | $5.87M | Sell |
242,166
-1,991,668
| -89% | -$48.3M | 0.01% | 1237 |
|
|
2024
Q4 | $46.6M | Sell |
2,233,834
-195,139
| -8% | -$4.07M | 0.04% | 545 |
|
|
2024
Q3 | $48.3M | Sell |
2,428,973
-43,960
| -2% | -$874K | 0.05% | 515 |
|
|
2024
Q2 | $38.3M | Buy |
2,472,933
+2,248,850
| +1,004% | +$34.8M | 0.04% | 570 |
|
|
2024
Q1 | $3.57M | Buy |
224,083
+124,238
| +124% | +$1.98M | ﹤0.01% | 1463 |
|
|
2023
Q4 | $1.68M | Buy |
99,845
+5,476
| +6% | +$92.1K | ﹤0.01% | 1791 |
|
|
2023
Q3 | $1.1M | Sell |
94,369
-69,974
| -43% | -$818K | ﹤0.01% | 1931 |
|
|
2023
Q2 | $2.21M | Buy |
+164,343
| New | +$2.21M | ﹤0.01% | 1653 |
|
|
2023
Q1 | – | Sell |
-167,435
| Closed | -$3.11M | – | 2377 |
|
|
2022
Q4 | $3.11M | Buy |
+167,435
| New | +$3.11M | ﹤0.01% | 1487 |
|
|
2022
Q3 | – | Sell |
-142,629
| Closed | -$1M | – | 2494 |
|
|
2022
Q2 | $1M | Sell |
142,629
-4,402
| -3% | -$30.9K | ﹤0.01% | 1986 |
|
|
2022
Q1 | $1.22M | Sell |
147,031
-8,535
| -5% | -$70.8K | ﹤0.01% | 1977 |
|
|
2021
Q4 | $1.05M | Buy |
155,566
+19,408
| +14% | +$131K | ﹤0.01% | 2032 |
|
|
2021
Q3 | $722K | Sell |
136,158
-107,904
| -44% | -$572K | ﹤0.01% | 2154 |
|
|
2021
Q2 | $1.4M | Sell |
244,062
-9,501
| -4% | -$54.6K | ﹤0.01% | 1948 |
|
|
2021
Q1 | $1.17M | Buy |
253,563
+20,353
| +9% | +$93.8K | ﹤0.01% | 1937 |
|
|
2020
Q4 | $779K | Sell |
233,210
-10,106
| -4% | -$33.8K | ﹤0.01% | 1992 |
|
|
2020
Q3 | $723K | Buy |
+243,316
| New | +$723K | ﹤0.01% | 1900 |
|